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Human cytochrome P450 (P450) enzymes are involved in the oxidation of natural products found in foods, beverages, and tobacco products and their
catalytic activities can also be modulated by components of the materials. The microsomal activation of aflatoxin B1 to the exo-8,9-epoxide is stim-
lated by flavone and 7,8-benzoflavone, and attenuated by the flavonoid naringenin, a major component of grapefruit. P4502E1 has been demon-
strated to play a potentially major role in the activation of a number of very low-molecular weight cancer suspects, including ethyl carbamate
(urethan), which is present in alcoholic beverages and particularly stone brandies. The enzyme (P4502E1) is also known to be inducible by ethanol.
Tobacco contains a large number of potential carcinogens. In human liver microsomes a significant role for P4501A2 can be demonstrated in the acti-
vation of cigarette smoke condensate. Some of the genotoxicity may be due to arylamines. P4501A2 is also inhibited by components of crude ciga-
rette smoke condensate. The tobacco-specific nitrosamines are activated by a number of P450 enzymes. Of those known to be present in human
liver, P4501A2, 2A6, and 2E1 can activate these nitrosamines to genotoxic products.-Environ Health Perspect 102(Suppl 99:4-53 (1994)
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Introduction
Many chemicals that are genotoxic or oth-
erwise initiate cancers are not inherently
dangerous in themselves but are activated
into electrophilic forms through metabo-
lism (1), often by the cytochrome P450
(P450) enzymes (2-4) (Table 1). A num-
ber of lines of epidemiological evidence
argue that diet is a major contributor to
cancer risk (5). Other important variables
include societal habits such as smoking,
other consumption oftobacco, and overuse
ofalcoholic beverages (5,6).
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There is a considerable body of evi-
dence indicating that alterations in the
pool of P450 enzymes can dramatically
influence tumor incidence in experimental
animals (7); in humans, the situation must
still be considered hypothetical (8).
Nevertheless there is ample evidence that
in vivo disposition ofdrugs in humans can
be influenced by diet (9) and some of the
dietary effects on tumor incidence may be
explainable in the context of our knowl-
edge regarding individual P450 enzymes.
However, the analysis of situations involv-
ing complex mixtures presents special
problems for consideration.
Results and Discussion
AflatoxinMetabolism andP4503A4
Aflatoxin B1 is one of the most notorious
mycotoxins that contaminate human food-
stuffs and poses a problem ofserious impor-
tance in many parts ofthe world (10). We
have investigated various aspects of the
metabolism (Figure 1) ofthis compound in
human liver microsomes and have shown
that P4503A4 can play a major role in its
oxidation to the 8,9-epoxide (11,12).
Recently we have found that P450 can
catalyze two oxidations ofaflatoxin B1, the
8,9-epoxidation and the 3ax-hydroxylation
(12). The former reaction renders the com-
pound dangerous while the latter (forma-
tion ofaflatoxin QI) is a detoxication step.
While both reactions appeared to be attrib-
utable to P4503A4, the addition of 7,8-
benzoflavone (x-naphthoflavone) was
shown to enhance the 8,9-epoxidation, as
expected (11-13), but to inhibit 3a-
hydroxylation. Although these results
seemed unusual, the same pattern was
demonstrated with the recombinant
enzyme (Figure 2). Thus the result has
been interpreted in terms of an allosteric
effect of the flavone on an extrasubstrate
binding site in P4503A4 (12). Such effects
of flavonoids are not only ofacademic but
also practical interest; flavonoids are com-
monly found in foods, and Conney and his
associates have demonstrated the direct
stimulatory effects of such compounds in
vivo in experimental animals (14).
The major stereoisomer of aflatoxin B1
8,9-epoxide is known to be the exo form
shown in Figure 1. However, we have
recently demonstrated that the endo isomer
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Table 1. Prooxicants and procarcinogens activated byhuman P450s a.
P-4501Al Benzo[alpyrene and other polyclyclic
hydrocarbons
P-4501A2 2-Acetylaminofluorene
2-Aminofluorene
2-Aminoanthracene
2-Amino-3-methylimiazo[4,5-f]quinoline
(IQ)
2-Amino-3,8-d methyl midazo-
[4,5-f]quinoline (MeIQ)
2-Amino-3,8-dimethylimidazo-
[4,5-fIquinoxaline (MelQx)
2-Amino-3,4,8-trimethylimidazo-
[4,5-f]quinoxaline (DiMelQx)
2-Amino-6-methyldipyrido-
[l,2-a:3',2'-dlimidazole (Glu P-1)
P-4502A6 N-Nitrosodimethylamine
N-Nitrosodiethylamine
N-Nitrosonornicotine
N-Nitrosonornicotine (NNN)
P-4502E1 N-Nitrosodimethylamine
N-Nitrosodiethylamine
N-Methyl-N-benzylnitrosamine
N-Nitrosnornicotine (NNN)
4-(Methylnitrosamino)-l-
(3-pyridyl)-l-butanone (NNK)
Chloroform
Methylene chloride
Trichloroethylene
Ethylene dichloride
Ethylene dibromide
1,2-Dichloropropane
P-4503A4 Aflatoxin B1
Aflatoxin G,
Sterigmatocystin
Senecionine
7,8-Dihydroxy-7,8-dihydrobenzo[alpyrene
9,1O-Dihydroxy-9,10-dihydroxobenzo[b]-fluoranthene
2-Amino-1-methyl-6-
phenylimidazol[4,5-b]pyridine (PhIP)
3-Amino-1-methyl-5H-pyrido[4,3-blindole
(Trp P-2)
2-Aminopyrido[1,2-a:3',2'-olimidazole
(Glu P-2)
2-Naphthylamine
4-Aminobiphenyl
2-Amino-1-methyl-6-phenylimidazo-
[4,5-b]pyridine (PhIP)
Acetaminophen
4-(Methylnitrosamino)-i -(3-pyridyl)-
1-butanone (NNK)
6-Nitrochrysene
4-(Methylnitrosamino)-l-(3-pyridyl)
1-Butanone(NNK)
4,4'-Methylene-bis(2-chloroaniline) (MOCA)
4-(Methylnitrosamino)-l-(3-pyridyl)-l-
butanol (NNAL)
N-Methyl-N-butyl-1-nitrosamine
Benzene
Carbon tetrachloride
Styrene
4-(Methyinitrosamino)-l-(3-pyridyl)-l-
butanol (NNAL)
Vinyl chloride
Vinyl bromide
Acrylonitrile
Ethyl carbamate
Vinyl carbamate
Acetaminophen
3,4-Dihydroxy-3,4-dihydro-
7,12-Dimethylbenz[alanthracene
6-Aminochrysene
tris-(2,3-Dibromopropyl)phosphate
1-Nitropyrene
17b-Estradiol
aThe purpose ofthis table is to summarize evidence for a major role of a single (human liver) P450 in the activation of
each chemical. Of course, other P450s may also contribute to some extent, particularly in some individuals where the
major enzyme is deficient. In some cases a chemical appears in .2 categories if evidence exists for substantial roles in
these cases. Forfurtherdiscussion seethetextand Guengerich and Shimada(4).
is formed as a minor product in chemical
oxidations and in microsomes (15). Mouse
liver cytosol glutathione (GSH) S-tran-
ferases react essentially only with the exo
isomer, while rat liver GSH S-tranferases
actually show greater efficiency in the reac-
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tion with the endo form (16,17). We have
found that rat and human liver microsomal
P450s form very little of the endo epoxide
(<1%) but in some human liver microsomal
preparations the extent of endo-8,9-epoxide
formation is sometimes as much as that of
0 0
Hf
0N4
0 0
H H, OH
GMH _b
H
OST
AFS1 wdlo.S,-"axdd/GSH
Figure 1. Oxidation ofaflatoxin B1 to exoand enao-8,9-epoxides andconjugation with GSH.
exo (Figure 3). The patterns indicate that
P4503A4 is probably not the enzyme form-
ing the endo epoxide; another (unknown)
P450(s) apparently transfers oxygen to this
face ofthe olefin. The endo epoxide appears
not to be capable offorming DNA adducts
and is not genotoxic in Salmonella
typhimurium TA100 or in the umu test
(<2% activity ofthe exoepoxide). Thus, the
stereochemistry can lead to a remarkable
difference in biological activity; however,
the ready formation of the endo epoxide
and its GSH conjugate by some human
liver enzymes suggests caution in the use of
biomarkers such as GSH conjugates and
mercapturic acids in considerations ofrisk.
Not all flavones stimulate aflatoxin
epoxidation (13). Recently Bailey et al.
(18) have demonstrated a remarkably
strong inhibition of in vivooxidation ofthe
dihydropyridine drugs nifedipine and
felodipine by relatively modest amounts of
grapefruit juice (but not orange juice). The
major natural product in grapefruit is
naringin (Figure 4), which can constitute
up to 10% ofthe dry weight and is respon-
sible for the bitter taste. When ingested it is
readily hydrolyzed to naringenin (Figure 4),
which has been shown to inhibit the oxida-
tions ofboth nifedipine and aflatoxin Bi in
human liver microsomes (20). The potency
of naringenin for P4503A4 inhibition
appears similar to that of cimetidine (21);
the questions of whether naringenin is
responsible for the observed in vivo effects
and whether aflatoxin metabolism can be
modulated in vivo remain unanswered.
P4502E1,Ethanol, andEthyl
Carbamate
Early studies with rodents suggested that
liver microsomal P450s might be involved
in ethanol oxidation and also be induced by
ethanol consumption (22-24). Ultimately
research in this area led to the discovery of
P4502E1 (25,26). Whether or not the oxi-
dation of ethanol by P4502E1 is a major
factor in its disposition has not been clearly
demonstrated but it is clear that ingestion
of ethanol (or certain other compounds)
can lead to increases in the level of the
enzyme, even in humans (27). However,
ethanol is also an inhibitor of the enzyme,
so experiments on induction are complex
and must be interpreted carefully.
It is of interest that P4502E1 has been
shown to contribute to the oxidation of
numerous small chemicals, many ofwhich
are cancer suspects, in human liver micro-
somes (26,28). These interactions are
probably of significance in that numerous
interactions with ethanol in experimental
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Figure Z Effect of 7,8-benzofluorene (a-naphthoflavone, aNF) on the oxidation of aflatoxin B1 by human P4503A4.
P4503A4was purified from human liver microsomes (Liver P4503A4) or microsomes prepared from Saccharomycescer-
eresiaeexpressing the cDNA clone NF 25(yeast P4503A4) and reconstituted with rabbit NADPH-P450 reductase and L-
a-1,2-dilauroyl-sn-glycero-3-phosphocholine, with a 50 pM concentration of the substrate aflatoxin B1. Aflatoxin Ql
(solid black bar)and aflatoxin B1 8,9-oxide (diagonal-lined graybar)were quantified, with the latter being trapped as the
GSH conjugatewiththe use ofmouse livercytosol inthe incubation mixture (12).
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Figure 3. Rates of oxidation of aflatoxin B1 to exo and
endo epoxides by microsomes prepared from different
human liver (HL) samples. The substrate concentration
was 16 pM and the diastereometric GSH conjugates
were quantitatively trapped in the presence of mouse
(exo) or rat (endo) liver cytosol and separated by HPLC as
described elsewhere (12).
animals can be explained in this way (26).
One substrate of P4502E1 is ethyl carba-
mate (urethan), which is ofinterest because
ofits widespread use as an injection vehicle
for patients in Japan and its presence in
alcoholic beverages, especially the so-called
stone brandies (29). Recently we have been
able to demonstrate the in vitro formation
of vinyl carbamate from ethyl carbamate
(30), thus providing support for the path-
way originally proposed by Dahl et al. (31)
(Figure 5). The carcinogenicity of ethyl
carbamate in humans is still unproven and
the impact ofthis pathway is yet unknown.
However, the research in this area has
shown the potential for ethanol as an
inducer and inhibitor of P450s and the
genetic potential of chemicals in alcoholic
beverages that require activation by P450
modulated by ethanol.
Tobacco Components andP4501A2,
2A6, and2E1
Obviously tobacco has been a target of
interest because ofthe extensive epidemiol-
ogy supporting its role in the production of
several human cancers. However, there are
thousands of chemicals present in tobacco
and tobacco smoke, and most major classes
of chemical carcinogens are represented
(6). Determining which are most signifi-
cant and the specific enzymes that con-
tribute to activation processes have been
very challenging tasks.
We carried out a series ofstudies with a
standard cigarette smoke condensate and
human liver microsomes (32). It was found
that (unknown) components ofcrude ciga-
rette condensate were quite inhibitory to
P4501A2, more dramatically than to other
P450s. Fractionation of the condensate
with "blue cotton" (copper phthalocyanine
cellulose) removed may of the inhibiting
components and yielded material which
could be activated by human liver micro-
somes to products genotoxic in the S.
typhimurium umuassay. We found that rat,
rabbit, and human liver P4501A2 enzymes
were all rather effective in this activation
and that some other human liver P450s
were not. P4501A2 has also been demon-
strated to activate many individual carcino-
genic arylamines (19). Many of these are
prominent in tobacco, as well as in
pyrolyzed meat, and the possibility can be
considered that they are major contributors
to the genotoxicity oftobacco, after activa-
tion by P4501A2 and other enzymes.
Indeed, both cigarette smoking and several
industrial arylamines have been implicated
in human bladder cancer.
Another class of known carcinogens
found in tobacco is the nitrosamines. The
metabolism of the tobacco-specific
nitrosamine 4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanone (NNK) is complex
and a briefoutline is presented in Figure 6
(33). At least three different reactions yield
reactive alkyl diahydroxides, and elucida-
tion ofprecise roles ofparticular chemicals
and enzymes is difficult, even starting with
a single compound and the apparent
absence of issues of stereochemistry. In a
series ofstudies done in collaboration with
Prof C-S. Yang and others found that
human P4501A2 played a role in the oxi-
dation of NNK to the specific stable end
products shown in Figure 6 (33). How-
ever, it is not known with certainty which
of these particular entities is most geno-
toxic in any of the various assays or in
tumor bioassays.
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Figure 4. Structures of flavones shown to modulate the
oxidation ofaflatoxin B1 byhuman P4503A4(11-13,19,20).
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Figure 5. Postulated scheme of activation of ethyl carba-
mate and reaction of vinyl carbamate epoxide with ade-
nine residues toyield 1,N6-e-adenine derivatives(30,31).
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Figure 6.Majorpathways postulated forthe metabolism ofthetobacco-specific nitrosamine NNK(33).
In general, the genotoxic response to
nitrosamines in in vitro assays is poor, and
it does not appear that the problem is a
deficiency in enzymatic oxidation. Indeed,
in our early work with the S. typhimurium
umu assays we did not find an appreciable
response to any of the nitrosamines we
examined (19). Recently we have found
that overexpression ofbacterial acetyl trans-
fer activity in the bacterium (S.
typhimurium NM2009) renders it not only
much more sensitive to N-hydroxy ary-
lamines but to oxidized nitrosamines as
well (34). We feel that the most likely
explanation is the acetylation of the alkyl
diazohydroxide (Figure 7). In support of
RN-CH2R' RN-CHR'-O-H
I [- - , R-N=N-OH + RCHO
N=O N O
1
I [Ac]
[RI 4 - [R-N=N'}----- R-N=N-OAc
Figure 7. Scheme depicting postulated enhancement of nitrosamine genotoxicity by acetyltransferase in S.
typhimurium(34).
this view, the acetyl derivative (of methyl
diazohydroxide), when activated by an
esterase preparation, also yielded an
enhanced response in the overexpressing
strain (34).
We utilized this system in the examina-
tion of a series of nitrosamines, including
N-nitrosdimethylamine, N-nitrosodiethy-
lamine, NNK, 4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanol (NNAL), and
N-nitrosonornicotine, the latter three being
particular to tobacco. Experiments involved
the use of purified human P450 enzymes,
correlation of catalytic activities in different
human liver microsomes, and chemical and
antibody inhibition of activity (umu test)
with human liver microsomes (35). The
results indicate that with all five nitrosa-
mines P4502E1 and P4502A6 appear to
have significant roles in activation; P4501A2
also appeared to make some contribution,
but no evidence for roles of P4503A4 and
P4502C enzymes was found (35).
Conclusions
The possible interactions involving sub-
strates, inhibitors, and inducers in complex
mixtures are considerable. Such is the case
with foodstuffs, tobacco, and alcoholic bev-
erages. Even with a single compound (e.g.,
aflatoxin B1) there is potential for different
enzymes to generate stereoisomers (of an
epoxide) with dramatically different biolog-
ical activities. Although these may be many
chemicals and enzymes to consider in
understanding mixtures, it may still be pos-
sible to develop rational plans to under-
stand interactions. Some ofthe approaches
we have used in our own work include in
vitroassays, simplified biological end points
even if the chemical basis for the response
is not yet known in every case, and strate-
gies designed to identify the most impor-
tant microsomal and cytosolic enzymes
contributing to an in vitro response.
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